237 related articles for article (PubMed ID: 3390864)
1. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.
Webster NJ; Green S; Jin JR; Chambon P
Cell; 1988 Jul; 54(2):199-207. PubMed ID: 3390864
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
Uht RM; Anderson CM; Webb P; Kushner PJ
Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
[TBL] [Abstract][Full Text] [Related]
3. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
4. Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor.
Zajchowski DA; Webster L; Humm R; White FA; Simmons SJ; Bartholdi M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):373-83. PubMed ID: 9449240
[TBL] [Abstract][Full Text] [Related]
5. Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor.
Green S; Chambon P
Nature; 1987 Jan 1-7; 325(6099):75-8. PubMed ID: 3025750
[TBL] [Abstract][Full Text] [Related]
6. Effects of steroid hormones and antihormones in cultured cells.
Jung-Testas I; Baulieu EE
Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens.
Drewes T; Clairmont A; Klein-Hitpass L; Ryffel GU
Eur J Biochem; 1994 Oct; 225(1):441-8. PubMed ID: 7925467
[TBL] [Abstract][Full Text] [Related]
8. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W
Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783
[TBL] [Abstract][Full Text] [Related]
9. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element.
Xing H; Haase S; Shapiro DJ
Biochem Biophys Res Commun; 1994 Jul; 202(2):888-95. PubMed ID: 8048961
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
Elgort MG; Zou A; Marschke KB; Allegretto EA
Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
[TBL] [Abstract][Full Text] [Related]
13. Interaction of proteins with transcriptionally active estrogen receptors.
Cavaillès V; Dauvois S; Danielian PS; Parker MG
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10009-13. PubMed ID: 7937828
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
15. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins.
Braselmann S; Graninger P; Busslinger M
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1657-61. PubMed ID: 8446579
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
17. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
18. Distinct classes of transcriptional activating domains function by different mechanisms.
Tasset D; Tora L; Fromental C; Scheer E; Chambon P
Cell; 1990 Sep; 62(6):1177-87. PubMed ID: 2205398
[TBL] [Abstract][Full Text] [Related]
19. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
McInerney EM; Tsai MJ; O'Malley BW; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10069-73. PubMed ID: 8816752
[TBL] [Abstract][Full Text] [Related]
20. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
